Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a small molecule organic chemical classified as a fluorene derivative with hydroxyimino and diacetic acid functional groups. It has the molecular formula C17H13NO7 and an average molecular weight of approximately 343.29 g/mol. The structure features a fluorene core substituted at positions 2 and 7 with oxy-linked acetic acid moieties and a hydroxyimino group at position 9. There is no publicly available detailed pharmacological or therapeutic information about this compound; it appears to be an experimental research chemical rather than an approved drug. Its mechanism of action is not documented in major drug databases or literature sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,2'-{[9-(hydroxyimino)-9H-fluorene-2,7-diyl]bis(oxy)}diacetic acid.